Abstract
During COVID-19 pandemic several public health measures were implemented by diverse countries to reduce the risk of COVID-19, including social distancing. Here we collected the minimal distance recommended by each country for physical distancing at the onset of the pandemic and aimed to examine whether it had an impact on the outbreak dynamics and how this specific value was chosen. Despite an absence of data on SARS-CoV-2 viral transmission at the beginning of the pandemic, we found that most countries recommended physical distancing with a precise minimal distance, between one meter/three feet and two meters/six feet. 45% of the countries advised one meter/three feet and 49% advised a higher minimal distance. The recommended minimal distance did not show a clear correlation with reproduction rate nor with the number of new cases per million, suggesting that the overall COVID-19 dynamics in each country depended on multiple interacting factors. Interestingly, the recommended minimal distance correlated with several cultural parameters: it was higher in countries with larger interpersonal distance between two interacting individuals in non-epidemic conditions, and it correlated with civil law systems, and with currency. This suggests that countries which share common conceptions such as civil law systems and currency unions tend to adopt the same public health measures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the European Research Council under the European Community’s Seventh Framework Program (FP7/2007-2013 Grant Agreement no. 337579) to VCO. DC was supported by a fellowship from Pohang University of Science and Technology, South Korea (Study Abroad scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
DC: redchai{at}postech.ac.kr, LEM: elmossadeq.layla{at}gmail.com, MR: michel.raymond{at}umontpellier.fr
Data Availability
Source code and supporting files for analyzing the data are available at a public Github repository: https://github.com/redchai/COVID-Distance-Project.
Abbreviations
- CDC
- Centers for Disease Control and Prevention
- CFA Franc
- Franc of the Financial Community of Africa
- COVID-19
- Coronavirus Disease 2019
- GLM
- Generalized Linear Model
- OxCGRT
- Oxford COVID-19 Government Response Tracker
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus 2
- SE
- standard error of the mean
- WHO
- World Health Organization
